Development of a cell-based high-throughput specificity screen using a hepatitis C virus-bovine viral diarrhea virus dual replicon assay.
about
New hepatitis C virus drug discovery strategies and model systemsDevelopment of a Novel Dicistronic Reporter-Selectable Hepatitis C Virus Replicon Suitable for High-Throughput Inhibitor ScreeningDiscovery and Characterization of Substituted Diphenyl Heterocyclic Compounds as Potent and Selective Inhibitors of Hepatitis C Virus ReplicationDevelopment of a Cell-Based Hepatitis C Virus Infection Fluorescent Resonance Energy Transfer Assay for High-Throughput Antiviral Compound ScreeningIdentification of Hepatitis C Virus NS5A InhibitorsHigh-throughput screening and rapid inhibitor triage using an infectious chimeric Hepatitis C virusNatural products that reduce rotavirus infectivity identified by a cell-based moderate-throughput screening assayPreclinical characterization of BMS-791325, an allosteric inhibitor of hepatitis C Virus NS5B polymerase.Inhibition of dengue virus by targeting viral NS4B proteinResistance analysis of the hepatitis C virus NS5A inhibitor BMS-790052 in an in vitro replicon system.Discovery of potent hepatitis C virus NS5A inhibitors with dimeric structures.Distinct functions of NS5A in hepatitis C virus RNA replication uncovered by studies with the NS5A inhibitor BMS-790052Potency and resistance analysis of hepatitis C virus NS5B polymerase inhibitor BMS-791325 on all major genotypes.In vitro activity of BMS-790052 on hepatitis C virus genotype 4 NS5A.Hepatitis C virus RNA elimination and development of resistance in replicon cells treated with BMS-790052Inactivated ORF virus shows antifibrotic activity and inhibits human hepatitis B virus (HBV) and hepatitis C virus (HCV) replication in preclinical modelsEffect on hepatitis C virus replication of combinations of direct-acting antivirals, including NS5A inhibitor daclatasvirPreclinical Profile and Characterization of the Hepatitis C Virus NS3 Protease Inhibitor Asunaprevir (BMS-650032).Cell-based Assays to Identify Inhibitors of Viral Disease.Cell viability assessment: toward content-rich platforms.Intragenic complementation of hepatitis C virus NS5A RNA replication-defective alleles.Biochemical evaluation of HCV NS3 protease inhibitors.Screening of hepatitis C virus inhibitors using genotype 1a HCV replicon cell lines.Inhibitors of HCV NS5A: From Iminothiazolidinones to Symmetrical Stilbenes.2,3-Dihydro-1,2-Diphenyl-substituted 4H-Pyridinone derivatives as new anti Flaviviridae inhibitors.Cell-based hepatitis C virus infection fluorescence resonance energy transfer (FRET) assay for antiviral compound screening.
P2860
Q26851159-D71A59CF-146F-4C9C-8E08-E462C5D3EBA6Q27478065-B28257D9-6AD2-4B2B-8FEC-A003DF20C304Q27485724-4B0C24D3-FB75-4955-BF2C-9D60A90657AEQ27490187-BD8E78E2-792C-4EC4-BF61-B4254B8B1757Q27490539-658B4153-CED2-4D07-9A7D-2A6395E1419AQ28482091-9B306FE0-5897-4CA8-B95E-D8648D132479Q33256133-6A0298A5-4222-4A4D-AE27-DB86B86E4B82Q33798031-8312B551-F834-4EA4-8285-A8DD22179B54Q34002195-5A0DB505-4636-4B6C-A86A-C44B598C528AQ34022926-5418E555-FAC3-4D1B-ABAB-314738C8150FQ34185327-99D2FE23-92CE-423A-B35E-C6807F81B4CBQ34185949-0B10E45B-7CFA-4F8C-9B14-C12B27D5D548Q34597529-22497355-2372-4518-BF52-65E1BCFEA7E4Q34634693-F8B0CB60-CFF7-4881-9C76-028D020D9FCEQ34634791-CFC6AD41-D1E9-4157-A9C3-2FD3D53DDDC0Q34997379-359C82B6-33B2-4BDB-BC96-8346B35B2482Q36276803-4DD3CD1D-DECC-4C5E-9536-5ED1C3B69C94Q36276835-C344B309-3850-4545-8772-7414A5A501A7Q37341010-65BC8601-CAFD-4D6D-9125-A99F0C61D213Q38028530-1EAE30D1-D86F-4920-9AB6-B4344D5F6634Q39227082-867B2C5B-1E88-4B48-AFE1-C4343F765990Q39478443-8DA9F58C-8C5D-448E-9650-082A6F130C4DQ39497196-2F64236F-9F2E-491A-A7AC-D1F22B2E9EB6Q39508189-715AC49F-1097-48C4-BF6E-E05B0A292E10Q39574740-11984136-A692-438F-A0BF-D0921BEF48D9Q39660432-CD2FD9C5-BDCD-47BE-9CEF-3D58DFA04A89
P2860
Development of a cell-based high-throughput specificity screen using a hepatitis C virus-bovine viral diarrhea virus dual replicon assay.
description
2005 nî lūn-bûn
@nan
2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Development of a Cell-Based Hi ...... rhea Virus Dual Replicon Assay
@nl
Development of a cell-based hi ...... hea virus dual replicon assay.
@ast
Development of a cell-based hi ...... hea virus dual replicon assay.
@en
type
label
Development of a Cell-Based Hi ...... rhea Virus Dual Replicon Assay
@nl
Development of a cell-based hi ...... hea virus dual replicon assay.
@ast
Development of a cell-based hi ...... hea virus dual replicon assay.
@en
prefLabel
Development of a Cell-Based Hi ...... rhea Virus Dual Replicon Assay
@nl
Development of a cell-based hi ...... hea virus dual replicon assay.
@ast
Development of a cell-based hi ...... hea virus dual replicon assay.
@en
P2093
P2860
P1476
Development of a cell-based hi ...... rhea virus dual replicon assay
@en
P2093
Donald R O'Boyle
Julie A Lemm
Karen Rigat
Lourdes Valera
Peter T Nower
Richard Colonno
P2860
P304
P356
10.1128/AAC.49.4.1346-1353.2005
P407
P50
P577
2005-04-01T00:00:00Z